Relationship Between Low Bone Mineral Density and Highly Active Antiretroviral Therapy Including Protease Inhibitors in HIV-Infected Patients

Javier Fernández-Rivera, R. García, Fernando Lozano, +7

HIV Clinical Trials

Six cycles of ABVD in the treatment of stage I and II Hodgkin's lymphoma: a pilot study.

A. Rueda, Emilio Alba, Nuria Ribelles, +3

Journal of Clinical Oncology

SEOM clinical guidelines for the treatment of head and neck cancer (2017)

Lara Carmen Iglesias Docampo, V. Arrazubi Arrula, N. Baste Rotllan, +7

Clinical & Translational Oncology

Neck CancerHnc DiagnosisCancer ManagementPathologySurgery +25

Adjuvant therapy with cetuximab for locally advanced squamous cell carcinoma of the oropharynx: results from a randomized, phase II prospective trial

A. Rueda, Ruth Vera, Alicia Lozano, +6

Annals of Oncology

Ii Prospective TrialNeoadjuvant TherapyMedicinePathologyCancer Treatment +5

Shift in the balance between circulating thrombospondin-1 and vascular endothelial growth factor in cancer patients: Relationship to platelet a-granule content and primary activation

Francisco Javier González, A. Rueda, Isabel Sevilla, +4

The International Journal of Biological Markers

Evolution of the Quorum network and the mobilome (plasmids and bacteriophages) in clinical strains of Acinetobacter baumannii during a decade

María López, A. Rueda, Javier Pérez-Florido, +9

Scientific Reports

Early‐acting cytokine‐driven <i>ex vivo</i> expansion of mobilized peripheral blood CD34⁺ cells generates post‐mitotic offspring with preserved engraftment ability in non‐obese diabetic/severe combined immunodeficient mice

Concha Herrera, J Sánchez, Armando Torres, +3

British Journal of Haematology

Involvement of K-RAS mutations and amino acid substitutions in the survival of metastatic colorectal cancer patients

Elísabeth Pérez-Ruiz, A. Rueda, Teresa Pereda, +6

Tumor Biology

NIVOLUMAB PLUS DOXORUBICIN, VINBLASTINE AND DACARBAZINE FOR NEWLY DIAGNOSED ADVANCED‐STAGE CLASSICAL HODGKIN LYMPHOMA: CHECKMATE 205 COHORT D 2‐YEAR FOLLOW‐UP

Stephen M. Ansell, Rod Ramchandren, Eva Domingo‐Doménech, +12

Hematological Oncology

ImmunoeditingImmunologyPathologyClassical Hodgkin LymphomaImmunotherapeutics +15

Gefitinib plus concomitant boost accelerated radiation (AFX-CB) and concurrent weekly cisplatin for locally advanced unresectable squamous cell head and neck carcinomas (SCCHN): A phase II study

A. Rueda, J. A. Medina, R. Galiana, +5

Journal of Clinical Oncology

Weekly CisplatinPhase Ii StudyMolecular InhibitionRadiation MedicineOncology +14